Learn more →
Back to Expert Scholars
Translational Medicine / 转化医学TROP2 ADC, Breast Cancer

Komal Jhaveri

MD, FACP

🏢Memorial Sloan Kettering Cancer Center🌐USA

Medical Oncologist

35
h-index
0
Key Papers
0
Key Contributions

👥Biography 个人简介

Dr. Komal Jhaveri is a breast oncologist at MSK who studies ADC resistance and optimal sequencing in breast cancer. Her research has addressed the critical clinical question of cross-resistance between TROP2-directed and HER2-directed ADCs and has identified molecular determinants of resistance to sacituzumab govitecan. She leads studies evaluating sequential ADC strategies in HR-positive and HER2-low metastatic breast cancer.

Share:

🧪Research Fields 研究领域

cross-ADC resistance mechanisms TROP2
sequential ADC breast cancer
sacituzumab govitecan after T-DXd
ADC resistance biomarkers
HR+ BC novel therapy

🎓Key Contributions 主要贡献

Representative Works 代表性著作

📄Data Sources 数据来源

Last updated: 2026-04-01 | All information from publicly available academic sources

关注 Komal Jhaveri 的研究动态

Follow Komal Jhaveri's research updates

留下邮箱,当我们发布与 Komal Jhaveri(Memorial Sloan Kettering Cancer Center)相关的新研究或访谈时,我们会通知你。

我们不会泄露你的信息,也不会发送无关内容。随时可以退订。

Explore More Experts

Discover the researchers shaping the future of cancer treatment